<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-15T18:57:54Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/4798" metadataPrefix="etdms">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/4798</identifier><datestamp>2026-02-06T12:54:15Z</datestamp><setSpec>com_10259_4365</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>com_10259_4883</setSpec><setSpec>col_10259_4366</setSpec><setSpec>col_10259_4884</setSpec></header><metadata><thesis xmlns="http://www.ndltd.org/standards/metadata/etdms/1.0/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.ndltd.org/standards/metadata/etdms/1.0/ http://www.ndltd.org/standards/metadata/etdms/1.0/etdms.xsd">
<title>Role of Seroalbumin in the Cytotoxicity of cis-Dichloro Pt(II) Complexes with (N^N)-Donor Ligands Bearing Functionalized Tails</title>
<creator>Pérez Arnáiz, Cristina</creator>
<creator>Leal, Jorge .</creator>
<creator>Busto Vázquez, Natalia</creator>
<creator>Carrión, María C. .</creator>
<creator>Rubio Antolin, Ana Rosa</creator>
<creator>Ortiz, Imanol .</creator>
<creator>Barone, Giampaolo</creator>
<creator>Díaz de Greñu Puertas, Borja</creator>
<creator>Santolaya, Javier</creator>
<creator>Leal Villalba, José María</creator>
<creator>Vaquero Gutiérrez, Mónica</creator>
<creator>Jalón Sotés, Félix Ángel</creator>
<creator>Manzano, Blanca R. .</creator>
<creator>García Ruiz, Begoña</creator>
<description>Given the potent anticancer properties of cisdiamminedichloroplatinum(&#xd;
II) and knowing its mode of action, we&#xd;
synthesized four new cis-[PtCl2(N^N)] organoplatinum complexes, two&#xd;
with N-substituted pbi ligands (pbiR = 1-R-2-(2-pyridyl)benzimidazole)&#xd;
(namely, 1 and 2) and two more with 4,4′-disubstituted bpy ligands (bpy =&#xd;
2,2′-bipyridine) (namely, 3 and 4). We explored their cytotoxicity and&#xd;
ability to bind to deoxyguanosine monophosphate (dGMP), DNA, and&#xd;
albumin models. By 1H NMR and UV−vis spectroscopies, circular&#xd;
dichroism, agarose gel electrophoresis, differential scanning calorimetry&#xd;
measurements, and density functional theory calculations, we verified that&#xd;
only 3 can form aquacomplex species after dimethyl sulfoxide solvation;&#xd;
surprisingly, 1, 2, and 3 can bind covalently to DNA, whereas 4 can form a noncovalent complex. Interestingly, only complexes 1&#xd;
and 4 exhibit good cytotoxicity against human ovarian carcinoma (HeLa) cell line, whereas 2 and 3 are inactive. Although lung&#xd;
carcinoma (A549) cells are more resistant to the four platinum complexes than HeLa cells, when the protein concentration in the&#xd;
extracellular media is lower, the cytotoxicity becomes substantially enhanced. By native electrophoresis of bovine seroalbumin&#xd;
(BSA) and inductively coupled plasma mass spectrometry uptake studies we bear out, on one hand, that 2 and 3 can interact&#xd;
strongly with BSA and its cellular uptake is negligible and, on the other hand, that 1 and 4 can interact with BSA only weakly, its&#xd;
cellular uptake being higher by several orders. These results point up the important role of the protein binding features on their&#xd;
biological activity and cellular uptake of cis-“PtCl2” derivatives. Our results are valuable in the future rational design of new&#xd;
platinum complexes with improved biological properties, as they expose the importance not only of their DNA binding abilities&#xd;
but also of additional factors such as protein binding.</description>
<date>2018-05-21</date>
<date>2019-05-21</date>
<date>2018-05-21</date>
<type>info:eu-repo/semantics/article</type>
<identifier>0020-1669</identifier>
<identifier>http://hdl.handle.net/10259/4798</identifier>
<identifier>10.1021/acs.inorgchem.8b00713</identifier>
<language>eng</language>
<relation>Inorganic chemistry, 2018, V. 57, n 10, p. 6124-6134</relation>
<relation>http://dx.doi.org/10.1021/acs.inorgchem.8b00713</relation>
<relation>info:eu-repo/grantAgreement/MINECO/CTQ2014-58812-C2-2-R</relation>
<relation>info:eu-repo/grantAgreement/MINECO/CTQ2014-58812-C2-1-R,</relation>
<relation>info:eu-repo/grantAgreement/MINECO/CTQ2015-70371-REDT</relation>
<relation>info:eu-repo/grantAgreement/JCyL/BU042U16</relation>
<relation>info:eu-repo/grantAgreement/FundaciónLaCaixa/LCF/PR/PR12/11070003)</relation>
<rights>info:eu-repo/semantics/openAccess</rights>
<publisher>American Chemical Society</publisher>
</thesis></metadata></record></GetRecord></OAI-PMH>